Area of research
Immunology · Rheumatology
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, and Dermatology and Skin Diseases.
The obesity–inflammation axis in psoriatic disease: mechanisms and therapeutic strategies
Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial
Defining On-Treatment Remission in Plaque Psoriasis
Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council
The association between obesity and efficacy of psoriasis therapies: An expert consensus panel
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis
Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis
Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trial
Psoriatic arthritis: A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis
Psoriatic arthritis: A comprehensive review for the dermatologist–Part II: Screening and management
Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study
GRAPPA 2023 Annual Meeting Report: Hot Topic Session on Measurement of Musculoskeletal Symptoms in Psoriatic Disease
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting
Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study
Screening and Referral Strategies for the Early Recognition of Psoriatic Arthritis Among Patients With Psoriasis: Results of a GRAPPA Survey
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting
332 Improvement in symptoms of atopic dermatitis (AD) and AD-related quality of life with dupilumab treatment in adults: 24-week results of the DUPISTAD study
335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment
43006 Dupilumab Improves Sleep in Adults with Moderate-to-Severe Atopic Dermatitis over 24 Weeks
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
Does biologic therapy impact the development of PsA among patients with psoriasis?
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
Acquisition of High-Impact Computational Resources for Cyber-Enabled Research and Education
Upgrade of 300 MHz Solid State NMR
MRI: Development of a Colloidal Force-Distance-Adsorption Apparatus for Particle Science Research and Education
Proximal Adsorption in Colloidal Systems
Chemistry of Iridium Hydride Complexes Synthesized by Addition of Non-Metal Hydrides
Synthesis and Study of Iridium Hydride Complexes Created by Addition of E-H Molecules(E = H,B,C,N,O)